Publicador de contenidos

Investigación

VINCI

Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique

Duración
01/10/2017 - 30/09/2022
Financiadores
PEPFAR, Centres for Disease control and Prevention

Efforts in HIV prevention and treatment over the last decade have led to a worldwide reduction of 35% in the number of new HIV infections since 2000 and a 45% reduction in HIV-related deaths. Universal HIV testing and antiretroviral treatment (ART) has been recommended to reach the Joint United Nations Programme on HIV/AIDS 90-90-90 targets and end the AIDS epidemic by 2030. This implies identifying, initiating, and maintaining an additional 11.8 million individuals on ART by 2020 beyond and above the 18.2 million already in ART. However, in resource-limited settings, reaching universal targets is challenging and priorities must be set in order to maximize the efficient use of resources without jeopardizing equity and access to early ART. Fine-tuning a portfolio of strategies for HIV testing and counseling (HTC) and linkage will be necessary to ensure nobody is left behind. Once diagnosed with HIV, linkage and retention is fraught with obstacles which contribute to LTFU at different stages of the continuum of care.

Objective

The overarching objective of the VINCI project is to improve efficiency and equity of HTC provision and linkage to ART initiation. More specifically, the VINCI project seeks to evaluate a Ministry of Health training intervention aimed at improving clinician judgment for identifying and offering HTC in the context of Provider Initiated Counselling and Testing (PICT). Also, the project seeks to identify and describe the HIV-positive populations missed by clinician risk-guided PICT prior to and after training.

VINCI is a collaboration between ISGlobal, Fundaçao Manhiça, Fundación Ariel and the Mozambican National Ministry of Health.

Total Funding

2 million USD

Nuestro equipo

Equipo ISGlobal

Otros proyectos

Ver proyectos pasados

COMBACTE

Combatiendo la Resistencia Bacteriana en Europa

GAMA

Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting

COMBACTE-CARE

Combatting Bacterial Resistance in Europe - Carbapenem Resistance

MAMAH

Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

INTE-AFRICA

Integrating and decentralizing diabetes and hypertension services in Africa

ICARIA

Improving Care through Azithromycin Research for Infants in Africa

PreFIT

Predicting the Future: Incipient Tuberculosis

ANTICOV

Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19

Stool4TB

Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV

TB-RECONNECT

Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status

SToolNIH

Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring

END-VOC

ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)

TwinAir

Digital Twins Enabled Indoor Air Quality Management for Healthy Living

ENDÈMIC

Community knowledge generation through scientific culture, urban ecology and art

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

Hepatitis C Free Baleares

Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.

FLAVOBAC

Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias